Joe B Putnam

Summary

Affiliation: Vanderbilt University
Country: USA

Publications

  1. ncbi request reprint Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients
    Zhongxing Liao
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 60:1484-93. 2004
  2. ncbi request reprint Invited commentary
    Joe B Putnam
    Department of Thoracic Surgery, Vanderbilt University, 2971 The Vanderbilt Clinic, 1301 22nd Ave S, Nashville, TN 37232 5734, USA
    Ann Thorac Surg 83:424. 2007
  3. ncbi request reprint Is resection necessary for esophageal carcinoma?
    Joe B Putnam
    Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA
    Semin Oncol 32:S21-4. 2005
  4. ncbi request reprint Invited commentary
    Joe B Putnam
    Department of Thoracic Surgery, Vanderbilt University, 2971 The Vanderbilt Clinic, Nashville, TN 37232 5734, USA
    Ann Thorac Surg 81:285. 2006
  5. pmc Prognostic factors for resected non-small cell lung cancer with pN2 status: implications for use of postoperative radiotherapy
    Luigi Moretti
    Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA
    Oncologist 14:1106-15. 2009
  6. pmc Thoracic operations for pulmonary nodules are frequently not futile in patients with benign disease
    Eric L Grogan
    Department of Thoracic Surgery, Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA
    J Thorac Oncol 6:1720-5. 2011
  7. pmc Obesity increases operating room time for lobectomy in the society of thoracic surgeons database
    Jamii B St Julien
    Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA
    Ann Thorac Surg 94:1841-7. 2012
  8. pmc Poor survival for veterans with pathologic stage I non-small-cell lung cancer
    Jamii B St Julien
    Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, TN 37232, USA
    Am J Surg 204:637-42. 2012
  9. pmc Added value of a serum proteomic signature in the diagnostic evaluation of lung nodules
    Chad V Pecot
    Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA
    Cancer Epidemiol Biomarkers Prev 21:786-92. 2012
  10. pmc Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease
    Stephen Deppen
    Department of Thoracic Surgery, Vanderbilt Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA
    Ann Thorac Surg 92:428-32; discussion 433. 2011

Detail Information

Publications54

  1. ncbi request reprint Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients
    Zhongxing Liao
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 60:1484-93. 2004
    ..To evaluate the effect of surgical resection on the outcome of patients with clinical Stage II or III cancer of the esophagus treated with concurrent chemoradiotherapy...
  2. ncbi request reprint Invited commentary
    Joe B Putnam
    Department of Thoracic Surgery, Vanderbilt University, 2971 The Vanderbilt Clinic, 1301 22nd Ave S, Nashville, TN 37232 5734, USA
    Ann Thorac Surg 83:424. 2007
  3. ncbi request reprint Is resection necessary for esophageal carcinoma?
    Joe B Putnam
    Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA
    Semin Oncol 32:S21-4. 2005
    ..Greater attention should be given to improving staging procedures and to measuring improvement in quality of life as a treatment outcome to determine the optimal role of resection in treatment of esophageal cancer...
  4. ncbi request reprint Invited commentary
    Joe B Putnam
    Department of Thoracic Surgery, Vanderbilt University, 2971 The Vanderbilt Clinic, Nashville, TN 37232 5734, USA
    Ann Thorac Surg 81:285. 2006
  5. pmc Prognostic factors for resected non-small cell lung cancer with pN2 status: implications for use of postoperative radiotherapy
    Luigi Moretti
    Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA
    Oncologist 14:1106-15. 2009
    ..Here, we investigated the association between different clinicopathological features and postoperative therapy and local control and survival in patients with resected pN2 NSCLC...
  6. pmc Thoracic operations for pulmonary nodules are frequently not futile in patients with benign disease
    Eric L Grogan
    Department of Thoracic Surgery, Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA
    J Thorac Oncol 6:1720-5. 2011
    ....
  7. pmc Obesity increases operating room time for lobectomy in the society of thoracic surgeons database
    Jamii B St Julien
    Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA
    Ann Thorac Surg 94:1841-7. 2012
    ..Obesity has become a major epidemic in the United States. Although research suggests obesity does not increase major morbidity or mortality after thoracic operations, it likely results in greater use of health care resources...
  8. pmc Poor survival for veterans with pathologic stage I non-small-cell lung cancer
    Jamii B St Julien
    Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, TN 37232, USA
    Am J Surg 204:637-42. 2012
    ..Pathologic stage (pStage) IA and IB non-small-cell lung cancer (NSCLC) has a median survival time of 119 and 81 months, respectively. We describe the outcomes of veterans with pStage I NSCLC...
  9. pmc Added value of a serum proteomic signature in the diagnostic evaluation of lung nodules
    Chad V Pecot
    Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA
    Cancer Epidemiol Biomarkers Prev 21:786-92. 2012
    ..We hypothesized that a serum proteomic signature may add diagnostic information beyond that provided by combined clinical and radiographic data...
  10. pmc Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease
    Stephen Deppen
    Department of Thoracic Surgery, Vanderbilt Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA
    Ann Thorac Surg 92:428-32; discussion 433. 2011
    ..We examined the diagnostic accuracy of FDG-PET in patients with known or suspected non-small cell lung cancer treated at our institution...
  11. doi request reprint Tissue-based coronary surgery simulation: medical student deliberate practice can achieve equivalency to senior surgery residents
    Jonathan C Nesbitt
    Vanderbilt University Medical Center, Department of Thoracic Surgery, Nashville, Tenn, USA
    J Thorac Cardiovasc Surg 145:1453-8; discussion 1458-9. 2013
    ....
  12. pmc Existing general population models inaccurately predict lung cancer risk in patients referred for surgical evaluation
    James M Isbell
    Department of Surgery, Vanderbilt Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA
    Ann Thorac Surg 91:227-33; discussion 233. 2011
    ..We evaluated these models in a surgical population to determine the accuracy of existing models to predict benign or malignant disease...
  13. pmc Diagnostic characteristics of a serum biomarker in patients with positron emission tomography scans
    Eric L Grogan
    Department of Thoracic Surgery, Vanderbilt Ingram Cancer Center, Nashville, Tennessee 37232, USA
    Ann Thorac Surg 89:1724-8; discussion 1728-9. 2010
    ..We hypothesized that our serum biomarker improves diagnostic accuracy by providing greater specificity...
  14. ncbi request reprint Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer
    Stephen G Swisher
    Department of Thoracic Surgery, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Ann Thorac Surg 78:1152-60; discussion 1152-60. 2004
    ....
  15. ncbi request reprint Cardiovascular complications after lung surgery
    John M Karamichalis
    Department of Thoracic Surgery, Vanderbilt University Medical Center, 1301 22nd Avenue South, 2971 The Vanderbilt Clinic, Nashville, TN 37232 5734, USA
    Thorac Surg Clin 16:253-60. 2006
    ..Although postoperative cardiac events cannot be completely eliminated from the thoracic surgery population, the prevention, treatment, and follow-up strategies outlined herein can attenuate these significant morbid and mortal events...
  16. ncbi request reprint Cytoplasmic clusterin expression is associated with longer survival in patients with resected non small cell lung cancer
    Jeffrey M Albert
    Department of Radiation Oncology, Vanderbilt University, 1301 Medical Center Drive, B 902 The Vanderbilt Clinic, Nashville, TN 37232 5671, USA
    Cancer Epidemiol Biomarkers Prev 16:1845-51. 2007
    ..Previous studies have examined the prognostic value of clusterin expression in various malignancies. In the present study, we examined clusterin staining in tumors resected from patients with non-small cell lung cancer (NSCLC)...
  17. doi request reprint Successful treatment of atrioesophageal fistula by cervical esophageal ligation and decompression
    Jamii St Julien
    Department of Surgery, The Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA
    Ann Thorac Surg 91:e85-6. 2011
    ..Here, we describe the successful management of an atrioesophageal fistula by cervical esophageal ligation and decompression, along with gastric drainage...
  18. doi request reprint Outcomes of surgery for chest wall sarcomas
    Joe B Putnam
    Department of Thoracic Surgery, Vanderbilt University Medical Center, 1313 21st Avenue South, 609 Oxford House, Nashville, TN 37232 4682, USA
    Thorac Surg Clin 20:535-42. 2010
    ..Early diagnosis of chest wall sarcomas, confirmation by an experienced sarcoma pathologist, and multidisciplinary discussion before treatment initiation, are all required for optimal and successful therapy...
  19. pmc Lung cancer diagnosis from proteomic analysis of preinvasive lesions
    S M Jamshedur Rahman
    Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Mass Spectrometry Research Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37232 6838, USA
    Cancer Res 71:3009-17. 2011
    ..These results show that proteomic analysis of endobronchial lesions may facilitate the diagnosis of lung cancer and the monitoring of high-risk individuals for lung cancer in surveillance and chemoprevention trials...
  20. ncbi request reprint Talc pleurodesis for malignant effusions is preferred over the pleurx catheter (pro position)
    Jared L Antevil
    Department of Thoracic Surgery, Vanderbilt University Medical Center, 1301 22nd Avenue South, 2971 The Vanderbilt Clinic, Nashville, Tennessee 37232 5734, USA
    Ann Surg Oncol 14:2698-9. 2007
  21. ncbi request reprint The rationale for adjuvant chemotherapy in stage I non-small cell lung cancer
    Leora Horn
    Division of Hematology and Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
    J Thorac Oncol 2:377-83. 2007
    ..The treatment algorithm is based on currently available tumor- and host-related factors that affect prognosis...
  22. doi request reprint Does positron emission tomography prevent nontherapeutic pulmonary resections for clinical stage IA lung cancer?
    Benjamin D Kozower
    Department of Surgery, University of Virginia Health System, Charlottesville, Virginia 22908 0679, USA
    Ann Thorac Surg 85:1166-9; discussion 1169-70. 2008
    ..This study evaluates whether PET prevents nontherapeutic pulmonary resections in clinical stage IA patients by finding advanced disease or by declaring a nodule as benign...
  23. doi request reprint Lymph node analysis in esophageal resection: American College of Surgeons Oncology Group Z0060 trial
    Nirmal K Veeramachaneni
    Division of Cardiothoracic Surgery, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Ann Thorac Surg 86:418-21; discussion 421. 2008
    ..The objective of this study was to review the current practice of American surgeons with regard to lymph node assessment during esophageal resection...
  24. ncbi request reprint Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy
    Stephen G Swisher
    Department of Thoracic and Cardiovascular Surgery, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Clin Cancer Res 9:93-101. 2003
    ..We designed a prospective single arm Phase II study to evaluate the feasibility and mechanisms of apoptosis induction after Ad-p53 (INGN 201) gene transfer and radiation therapy in patients with non-small cell lung cancer...
  25. ncbi request reprint The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution
    Linda W Martin
    Departments of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, Tex, USA
    J Thorac Cardiovasc Surg 130:1601-10. 2005
    ..To determine which treatment factors are associated with improved survival, we evaluated outcomes for these patients at our institution over a 16-year period...
  26. ncbi request reprint Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy
    Stephen G Swisher
    Department of Thoracic and Cardiovascular Surgery, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Thorac Cardiovasc Surg 123:175-83. 2002
    ..A subset of these patients have local relapse without distant metastases and therefore have no other curative intent treatment option but salvage esophagectomy...
  27. ncbi request reprint Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters
    Hoon K Lee
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Int J Radiat Oncol Biol Phys 57:1317-22. 2003
    ..To clarify the relationship between the percentage of lung receiving low radiation doses with concurrent chemotherapy and the occurrence of postoperative pulmonary complications in the treatment of esophageal carcinoma...
  28. ncbi request reprint Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer
    Stephen G Swisher
    Department of Thoracic and Cardiovascular Surgery, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 57:120-7. 2003
    ..To evaluate the long-term outcome of chemotherapy, chemoradiotherapy, and surgery for patients with locoregionally advanced esophageal cancer...
  29. ncbi request reprint Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction
    Jaffer A Ajani
    Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Cancer 100:2347-54. 2004
    ..Patients with localized esophageal carcinoma often develop locoregional and distant disease recurrence. The current study investigated the outcome of a new chemotherapy combination as induction therapy before chemoradiotherapy...
  30. ncbi request reprint Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer
    Amir Onn
    Department of Thoracic, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Clin Cancer Res 10:136-43. 2004
    ..Then we correlated these data with patient clinical outcome...
  31. ncbi request reprint Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical esophageal resection
    Banke Agarwal
    Department of GI Medicine and Nutrition, Medical Oncology and Thoracic and Cardiovascular Surgery, MD Anderson Cancer Center, Houston, Texas, USA
    Am J Gastroenterol 99:1258-66. 2004
    ..Based on these data, we reevaluated the role of EUS in identifying patients who maximally benefit from surgical esophageal resection after preoperative chemoXRT...
  32. pmc Treatment outcomes of resected esophageal cancer
    Wayne Hofstetter
    Department of Thoracic and Cardiovascular Surgery, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Ann Surg 236:376-84; discussion 384-5. 2002
    ..To assess the evolution of treatment and outcome for resected esophageal cancer at a single institution...
  33. ncbi request reprint 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma
    Stephen G Swisher
    Department of Thoracic and Cardiovascular Surgery, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 101:1776-85. 2004
    ..Preliminary reports suggest that FDG-PET may be predictive of the response of esophageal carcinoma patients to preoperative CRT...
  34. ncbi request reprint Preoperative chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidity
    David C Rice
    Department of Thoracic and Cardiovascular Surgery, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Ann Thorac Surg 79:391-7; discussionn 391-7. 2005
    ..Preoperative chemotherapy and radiation therapy are often administered to patients with esophageal cancer. Despite an aging population, little data exist regarding feasibility of preoperative therapy in elderly patients...
  35. ncbi request reprint New and evolving treatment methods for pulmonary metastases
    Joe B Putnam
    Department of Thoracic and Cardiovascular Surgery, M D Anderson Cancer Institute, 1515 Holcombe Boulevard Box 445, Houston, TX 77030 4095, USA
    Semin Thorac Cardiovasc Surg 14:49-56. 2002
    ..Experimental radiofrequency ablation techniques are rarely applicable. Combinations of resection of macrometastases with treatment of occult micrometastases may be best in improving disease-free and overall survival...
  36. ncbi request reprint Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the International Registry of Lung Metastases
    Godehard Friedel
    Department of Thoracic Surgery, Klink Schillerhoehe, Solitudestrasse 18, D 70839 Gerlingen, Germany
    Eur J Cardiothorac Surg 22:335-44. 2002
    ..Although the prognosis after resection of isolated metastases to the lung is much better than after chemotherapy most oncologists and gynecologists disapprove of lung metastasectomy...
  37. ncbi request reprint Irinotecan/cisplatin followed by 5-FU/paclitaxel/radiotherapy and surgery in esophageal cancer
    Jaffer A Ajani
    Department of Gastrointestinal Medical Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Oncology (Williston Park) 17:20-2. 2003
    ..Our preliminary data suggest that the proportion of patients with significant pathologic response can be increased by using the three-step strategy...
  38. ncbi request reprint The risk of second primary tumors after resection of stage I nonsmall cell lung cancer
    David Rice
    Department of Thoracic and Cardiovascular Surgery, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Ann Thorac Surg 76:1001-7; discussion 1007-8. 2003
    ..The overall effect of SPLC on survival after resection of stage I NSCLC is unknown. Here we report the incidence, management, and outcome of SPLC in a large prospective cohort of patients who underwent careful follow-up...
  39. ncbi request reprint Association of Ki-67, p53, and bcl-2 expression of the primary non-small-cell lung cancer lesion with brain metastatic lesion
    Robbin S Bubb
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 53:1216-24. 2002
    ..brain lesions) is similar...
  40. ncbi request reprint Increased phospho-AKT (Ser(473)) expression in bronchial dysplasia: implications for lung cancer prevention studies
    Anne S Tsao
    Department of Thoracic Head and Neck Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Cancer Epidemiol Biomarkers Prev 12:660-4. 2003
    ..Given its role as a mediator of malignant transformation, p-AKT should be investigated as a potential target in future lung cancer prevention studies...
  41. ncbi request reprint Epidermal growth factor receptor, cyclooxygenase-2, and BAX expression in the primary non-small cell lung cancer and brain metastases
    Ivan Milas
    Departments of Radiation Oncology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Clin Cancer Res 9:1070-6. 2003
    ..The purpose is to identify biological markers that predict brain metastasis and treatment outcome in non-small cell lung cancer (NSCLC)...
  42. ncbi request reprint Malignant pleural effusions
    Joe B Putnam
    Department of Thoracic and Cardiovascular Surgery, The University of Texas, M D Anderson Cancer Center, 1515 Holcombe Boulevard, Box 445 Houston, TX 77030 4095, USA
    Surg Clin North Am 82:867-83. 2002
    ..Alternative techniques of tube thoracostomy, drainage, and sclerosis or thoracoscopy with drainage and talc poudrage also have benefits but are associated with variable hospitalization and increased medical costs...
  43. ncbi request reprint The potential role of aprotinin in the perioperative management of malignant tumors
    Ara A Vaporciyan
    Department of Thoracic and Cardiovascular Surgery, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Box 445, Houston, TX 77030, USA
    J Am Coll Surg 198:266-78. 2004
  44. ncbi request reprint Inflammatory gene polymorphisms influence risk of postoperative morbidity after lung resection
    Andrew D Shaw
    Division of Anesthesiology and Critical Care Medicine, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Ann Thorac Surg 79:1704-10. 2005
    ..We hypothesized that proinflammatory alleles at candidate loci would predispose patients undergoing lung resection to cardiopulmonary complications with a presumed inflammatory cause...
  45. ncbi request reprint Limited-stage small-cell lung cancer (stages I-III): observations from the National Cancer Data Base
    Laurie E Gaspar
    Department of Radiation Oncology, University of Colorado at Denver and Health Sciences Center, Aurora, CO 80045 0510, USA
    Clin Lung Cancer 6:355-60. 2005
    ..These results demonstrate the continued need for the evaluation of new treatments in this group of patients...
  46. ncbi request reprint Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial
    Mark S Allen
    Ann Thorac Surg 81:1013-9; discussion 1019-20. 2006
    ..Little prospective, multiinstitutional data exist regarding the morbidity and mortality after major pulmonary resections for lung cancer or whether a mediastinal lymph node dissection increases morbidity and mortality...
  47. ncbi request reprint Operative trials: the opportunity beckons-an update on the American College of Surgeons Oncology Group
    Y Nancy You
    Department of Surgery, Mayo Clinic, Rochester, MN 55902, USA
    Surgery 139:455-9. 2006
  48. ncbi request reprint Yield of brain 18F-FDG PET in evaluating patients with potentially operable non-small cell lung cancer
    Katherine E Posther
    Department of Surgery, Duke Comprehensive Cancer Center, Duke University Medical Center, Durham, North Carolina, USA
    J Nucl Med 47:1607-11. 2006
    ..Here, we report the yield of brain PET in evaluating, for potential intracranial metastases, patients who have undergone previous brain CT or MRI with negative findings...
  49. ncbi request reprint The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial
    Bryan F Meyers
    Department of Surgery, Washington University School of Medicine, St Louis, MO
    J Thorac Cardiovasc Surg 133:738-45. 2007
    ....
  50. ncbi request reprint Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report
    Edward S Kim
    Department of Thoracic Head and Neck Medical Oncology, Thoracic Cardiovascular Surgery, Radiation Therapy, Pathology, Radiology, and Biostatistics, The University of Texas, M D Anderson Cancer Center, Houston, TX 77030, USA
    Lung Cancer 44:369-79. 2004
    ..To evaluate tumor resectability after induction chemotherapy and to determine disease-free and overall survival rates of patients with locally advanced unresectable thymoma that received a multimodal treatment regimen...
  51. ncbi request reprint Mentoring clinical trials in thoracic and cardiovascular surgery: a new role for the Society of Thoracic Surgeons
    Henning A Gaissert
    Division of Thoracic Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA
    Ann Thorac Surg 77:1874-5. 2004
  52. ncbi request reprint Use of aprotinin in extrapleural pneumonectomy: effect on hemostasis and incidence of complications
    Faisal Bakaeen
    The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA
    Ann Thorac Surg 84:982-6. 2007
    ..The purpose of this study was to examine the effect of aprotinin on blood loss in extrapleural pneumonectomy and to identify potential treatment-related complications...
  53. ncbi request reprint Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients
    Ara A Vaporciyan
    Department of Thoracic and Cardiovascular Surgery, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Box 445, Houston, TX 77030, USA
    J Thorac Cardiovasc Surg 127:779-86. 2004
    ..The purpose of this study was to identify risk factors associated with the onset of atrial fibrillation after thoracic surgery to allow more targeted interventions in patients with the highest risk...
  54. ncbi request reprint [18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer
    Ryohei Sasaki
    Department of Radiation Oncology, Unit 97, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    J Clin Oncol 23:1136-43. 2005
    ..To determine whether the standardized uptake value (SUV) of [(18)F]fluorodeoxyglucose uptake by positron emission tomography could be a prognostic factor for non-small-cell lung cancer (NSCLC)...